1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. News
  7. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Delayed Deutsche Boerse AG  -  05/27 02:02:20 am EDT
18.01 EUR   +2.62%
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SYNLAB : Raised to Buy by Barclays

01/17/2022 | 02:19am EDT

Barclays's analyst Hassan Al-Wakeel raises his rating from Neutral to Buy. The target price is increased from EUR 21 to EUR 25.


© MarketScreener with dpa-AFX Analyser 2022
All news about SYNLAB AG
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Financials
Sales 2022 3 163 M 3 389 M 3 389 M
Net income 2022 309 M 331 M 331 M
Net Debt 2022 1 508 M 1 616 M 1 616 M
P/E ratio 2022 12,6x
Yield 2022 1,69%
Capitalization 4 002 M 4 288 M 4 288 M
EV / Sales 2022 1,74x
EV / Sales 2023 1,85x
Nbr of Employees 25 750
Free-Float 75,7%
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 18,01 €
Average target price 22,49 €
Spread / Average Target 24,9%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer
David Raymond Ebsworth Chairman-Supervisory Board
Santiago Valor Garcia Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors